Form 4: OBIO CFO's Tax Withholding on RSU Vesting

Orchestra BioMed Holdings' CFO, Andrew Taylor, reported a disposition of shares to cover tax obligations related to restricted stock unit vesting.

Summary

• Andrew Taylor, Chief Financial Officer of Orchestra BioMed Holdings, Inc. (OBIO), reported a transaction on September 17, 2025.
• The transaction involved the disposition of 16,102 shares of common stock.
• These shares were withheld by the issuer to satisfy tax withholding obligations arising from the vesting of restricted stock units.
• The deemed price for these shares was $2.46 per share.
• No shares were sold in the open market as a result of this vesting and tax satisfaction.
• Following this transaction, Andrew Taylor beneficially owns 466,686 shares of common stock directly.

Sentiment

Score: 5

Explanation: The transaction is a routine tax withholding event related to RSU vesting, which is neutral in terms of company performance or insider sentiment. It is a standard administrative process for equity compensation.

Future Outlook

NA

Management Comments

• The disposition of shares represents the withholding by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
• No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations.

Industry Context

This is a routine insider transaction related to equity compensation and tax obligations, which is common across all industries for executives receiving restricted stock units. It does not reflect specific industry trends or competitive positioning.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine, non-market transaction for tax purposes.
• No direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Orchestra BioMed Holdings, OBIO, Andrew Taylor, CFO, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Tax Withholding, Equity Compensation